Effector Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Effector Therapeutics (EFTRW) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Effector Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $756 | 631k | 0.00 |
| 2024-03-31 | $85k | 631k | 0.14 |
| 2023-12-31 | $46k | 631k | 0.07 |
| 2023-09-30 | $48k | 631k | 0.08 |
| 2023-06-30 | $86k | 631k | 0.14 |
| 2023-03-31 | $47k | 631k | 0.08 |
| 2022-12-31 | $49k | 631k | 0.08 |
| 2022-06-30 | $101k | 506k | 0.20 |
| 2022-03-31 | $175k | 506k | 0.35 |
| 2021-12-31 | $445k | 506k | 0.88 |
| 2021-09-30 | $812k | 508k | 1.60 |
Top funds holding Effector Therapeutics
View all funds holding Effector Therapeutics